{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:27:51Z","timestamp":1773293271198,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.nut.2011.11.017","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T09:17:39Z","timestamp":1332926259000},"page":"722-726","source":"Crossref","is-referenced-by-count":28,"title":["Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments"],"prefix":"10.1016","volume":"28","author":[{"given":"Anna","family":"Alisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2011.11.017_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2011.11.017_bib2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAP.0b013e318220f59b","article-title":"Update on fatty liver disease and steatohepatitis","volume":"18","author":"Aly","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.nut.2011.11.017_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12519-009-0048-8","article-title":"Nonalcoholic fatty liver disease in children living in the obeseogenic society","volume":"5","author":"Hesham A-Kader","year":"2009","journal-title":"World J Pediatr"},{"key":"10.1016\/j.nut.2011.11.017_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jpeds.2009.06.014","article-title":"Pediatric nonalcoholic fatty liver disease in 2009","volume":"155","author":"Alisi","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.nut.2011.11.017_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MOP.0b013e32832cb16f","article-title":"The metabolic syndrome and nonalcoholic fatty liver disease in children","volume":"21","author":"Sundaram","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.nut.2011.11.017_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.nut.2011.11.017_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12519-009-0048-8","article-title":"Nonalcoholic fatty liver disease in children living in the obeseogenic society","volume":"5","author":"Hesham A-Kader","year":"2009","journal-title":"World J Pediatr"},{"key":"10.1016\/j.nut.2011.11.017_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1203\/PDR.0b013e3181da4798","article-title":"Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease","volume":"67","author":"Nobili","year":"2010","journal-title":"Pediatr Res"},{"issue":"Suppl 2","key":"10.1016\/j.nut.2011.11.017_bib9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1038\/ijo.2010.237","article-title":"Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child","volume":"34","author":"l\u2019Allemand-Jander","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.nut.2011.11.017_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2036.2008.03703.x","article-title":"Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease","volume":"28","author":"Barshop","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nut.2011.11.017_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1756283X09359964","article-title":"Treatment options for nonalcoholic fatty liver disease","volume":"3","author":"Lam","year":"2010","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.nut.2011.11.017_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7015-9-70","article-title":"The role of lifestyle changes in the management of chronic liver disease","volume":"9","author":"Nobili","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.nut.2011.11.017_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000323928","article-title":"Pathophysiology of non-alcoholic steatohepatitis and basis for treatment","volume":"29","author":"Pinzani","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.nut.2011.11.017_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2011.117","article-title":"Nonalcoholic fatty liver disease: targeted therapy in children\u2014what is the right way?","volume":"8","author":"Alisi","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2011.11.017_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.nut.2011.11.017_bib16","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.nut.2009.09.001","article-title":"Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease","volume":"26","author":"Elias","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2011.11.017_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.nut.2010.07.014","article-title":"Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease","volume":"27","author":"Ricci","year":"2011","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2011.11.017_bib18","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1517\/14656566.2011.587123","article-title":"Expert opinion on current therapies for nonalcoholic fatty liver disease","volume":"12","author":"Della Corte","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.nut.2011.11.017_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11892-008-0069-z","article-title":"Nutrition and nonalcoholic fatty liver disease in children","volume":"8","author":"Vos","year":"2008","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.nut.2011.11.017_bib20","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/01.meg.0000243872.86949.95","article-title":"Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy","volume":"18","author":"Tock","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2011.11.017_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.21262","article-title":"NAFLD in children: a prospective clinical\u2013pathological study and effect of lifestyle advice","volume":"44","author":"Nobili","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2011.11.017_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MPG.0b013e31803815d9","article-title":"Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease","volume":"44","author":"de Piano","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.nut.2011.11.017_bib23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3748\/wjg.14.1598","article-title":"Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children","volume":"14","author":"Wang","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nut.2011.11.017_bib24","article-title":"Effect of a 10-week weight-loss camp on fatty liver disease and insulin sensitivity in obese Danish children","author":"Gr\u00f8nb\u00e6k","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.nut.2011.11.017_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.22336","article-title":"Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2011.11.017_bib26","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.3748\/wjg.15.6017","article-title":"Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention","volume":"15","author":"Nobili","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nut.2011.11.017_bib27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ejcn.2010.35","article-title":"Dietary and physical activity patterns in children with fatty liver","volume":"64","author":"Mager","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.nut.2011.11.017_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jnutbio.2007.10.001","article-title":"The role of fatty acids in the development and progression of nonalcoholic fatty liver disease","volume":"19","author":"Gentile","year":"2008","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nut.2011.11.017_bib29","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gut.2006.112094","article-title":"Benefits of lifestyle modification in NAFLD","volume":"56","author":"Harrison","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.nut.2011.11.017_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1440-1746.2010.06253.x","article-title":"A fresh look at NASH pathogenesis. Part 1: the metabolic movers","volume":"25","author":"Larter","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2011.11.017_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/egh.11.19","article-title":"Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient\u2014death of a dogma from analysis of therapeutic studies?","volume":"5","author":"Lonardo","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2011.11.017_bib32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12325-009-0072-z","article-title":"Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status","volume":"26","author":"Stein","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.nut.2011.11.017_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.clinthera.2008.06.012","article-title":"Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study","volume":"30","author":"Nobili","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.nut.2011.11.017_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5448.2008.00450.x","article-title":"Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents","volume":"10","author":"Nadeau","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.nut.2011.11.017_bib35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.nut.2011.11.017_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756283X11403809","article-title":"The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis","volume":"4","author":"Van Wagner","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.nut.2011.11.017_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MPG.0b013e31818e04d1","article-title":"Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review","volume":"48","author":"Socha","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.nut.2011.11.017_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MCO.0b013e32833aae84","article-title":"Nonalcoholic fatty liver disease in children","volume":"13","author":"Alisi","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.nut.2011.11.017_bib39","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1365-2036.2006.03161.x","article-title":"Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease","volume":"24","author":"Nobili","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nut.2011.11.017_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3476(00)26774-7","article-title":"Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children","volume":"136","author":"Vajro","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.nut.2011.11.017_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jnutbio.2010.10.002","article-title":"Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms","volume":"22","author":"Iacono","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nut.2011.11.017_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2036.2009.04230.x","article-title":"Review article: omega-3 fatty acids\u2014a promising novel therapy for non-alcoholic fatty liver disease","volume":"31","author":"Masterton","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nut.2011.11.017_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2011.11.017_bib44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hep.24611","article-title":"Pathogen or damaged associated molecular patterns during non-alcoholic fatty liver disease development","volume":"54","author":"Alisi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2011.11.017_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20070456","article-title":"Cellular and molecular effects of n-3 polyunsaturated fatty acid on adipose tissue biology and metabolism","volume":"116","author":"Flachs","year":"2009","journal-title":"Cli Sci (Lond)"},{"key":"10.1016\/j.nut.2011.11.017_bib46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial","volume":"96","author":"Nobili","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nut.2011.11.017_bib47","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment","author":"Alisi","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.nut.2011.11.017_bib48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCO.0b013e32833a87cc","article-title":"Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation","volume":"13","author":"Tilg","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"suppl 7","key":"10.1016\/j.nut.2011.11.017_bib49","first-page":"57","article-title":"Therapy of nonalcoholic fatty liver disease: current status","volume":"60","author":"Duvnjak","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.nut.2011.11.017_bib50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s12325-008-0110-2","article-title":"Angiotensin receptor blockers in the treatment of NASH\/NAFLD: could they be a first-class option?","volume":"25","author":"Georgescu","year":"2008","journal-title":"Adv Ther"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900711004254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900711004254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T01:23:56Z","timestamp":1561512236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900711004254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":50,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0899900711004254"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2011.11.017","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}